KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Amortization - Intangibles (2016 - 2025)

Elevance Health (ELV) has disclosed Amortization - Intangibles for 17 consecutive years, with $164.0 million as the latest value for Q4 2025.

  • Quarterly Amortization - Intangibles fell 8.89% to $164.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $628.0 million through Dec 2025, up 8.28% year-over-year, with the annual reading at $628.0 million for FY2025, 8.28% up from the prior year.
  • Amortization - Intangibles for Q4 2025 was $164.0 million at Elevance Health, up from $162.0 million in the prior quarter.
  • The five-year high for Amortization - Intangibles was $247.0 million in Q4 2022, with the low at $80.0 million in Q1 2021.
  • Average Amortization - Intangibles over 5 years is $165.0 million, with a median of $162.0 million recorded in 2024.
  • The sharpest move saw Amortization - Intangibles skyrocketed 84.44% in 2022, then tumbled 50.64% in 2024.
  • Over 5 years, Amortization - Intangibles stood at $135.0 million in 2021, then skyrocketed by 82.96% to $247.0 million in 2022, then fell by 12.15% to $217.0 million in 2023, then dropped by 17.05% to $180.0 million in 2024, then dropped by 8.89% to $164.0 million in 2025.
  • According to Business Quant data, Amortization - Intangibles over the past three periods came in at $164.0 million, $162.0 million, and $147.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.